EVH – evolent health, inc class a (US:NASDAQ)

News

Evolent Health, Inc. (NYSE: EVH) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $40.00 price target on the stock.
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
Exclusive: Inside Wiz's acquisition of Gem Security [Fortune]
Define Ventures Welcomes Frank Williams as Venture Partner [Yahoo! Finance]
Recent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're still up 134% over 5 years [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com